Cover Image

Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease

Treatment with HMG-CoA reductase inhibitors (statins) reduces the morbidity and mortality of coronary artery disease (CAD). In addition to their lipid-lowering actions, pleiotropic effects of statins have been demonstrated. The aim of the present study was to assess if atorvastatin therapy has an im...

Full description

Saved in:
Bibliographic Details
Main Authors: Walter, Thomas (Author) , Szabo, Sebastian (Author) , Süselbeck, Tim (Author) , Borggrefe, Martin (Author) , Lang, Siegfried (Author) , Swoboda, Stefanie (Author) , Hoffmeister, Hans Martin (Author) , Dempfle, Carl-Erik (Author)
Format: Article (Journal)
Language:English
Published: 2010
In: Clinical drug investigation
Year: 2010, Volume: 30, Issue: 7, Pages: 453-460
ISSN:1179-1918
DOI:10.2165/11536270-000000000-00000
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2165/11536270-000000000-00000
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.2165/11536270-000000000-00000
Get full text
Author Notes:Thomas Walter, Sebastian Szabo, Tim Suselbeck, Martin Borggrefe, Siegfried Lang, Stefanie Swoboda, Hans Martin Hoffmeister and Carl-Erik Dempfle
Description
Summary:Treatment with HMG-CoA reductase inhibitors (statins) reduces the morbidity and mortality of coronary artery disease (CAD). In addition to their lipid-lowering actions, pleiotropic effects of statins have been demonstrated. The aim of the present study was to assess if atorvastatin therapy has an impact on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with CAD.
Item Description:Online veröffentlicht am 24. August 2012
Gesehen am 04.10.2023
Physical Description:Online Resource
ISSN:1179-1918
DOI:10.2165/11536270-000000000-00000

Similar Items